Dianthus Therapeutics, Inc. /DE/(DNTH)内部人交易:高管与董事近期交易
过去 18 个月,共有 8 位内部人为 Dianthus Therapeutics, Inc. /DE/(DNTH)报告了 128 笔 Form 4 交易(最近一笔 2026-11-12)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 29,276 | $523,455 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 17,724 | $1.6M |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 40,430 | $892,290 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 10,399 | $87,768 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 300 | $25,548 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 700 | $60,690 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 1,736 | $154,226 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 20,608 | $448,636 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 58,396 | $5.3M |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 2,064 | $189,042 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 1,301 | $28,323 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 1,260 | $27,808 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 2,561 | $230,849 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 1,744 | $37,967 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 1,300 | $28,691 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 3,044 | $274,051 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 1,339 | $29,150 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 买入 | 16,385 | $361,617 |
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 卖出 | 37,517 | $3.4M |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 700 | $73,073 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 7,928 | $796,209 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 6,771 | $686,376 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 3,501 | $358,467 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 1,100 | $113,520 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 买入 | 20,000 | $357,600 |
来源:SEC Form 4 申报文件 · 截至 2026-11-12